These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8293377)

  • 1. Paranoid psychosis induced by oxymetazoline nasal spray.
    Ticoll B; Shugar G
    CMAJ; 1994 Feb; 150(3):375-6. PubMed ID: 8293377
    [No Abstract]   [Full Text] [Related]  

  • 2. A study of the effect of nasal steroid sprays in perennial allergic rhinitis patients with rhinitis medicamentosa.
    Ferguson BJ; Paramaesvaran S; Rubinstein E
    Otolaryngol Head Neck Surg; 2001 Sep; 125(3):253-60. PubMed ID: 11555762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thunderclap headache and reversible segmental cerebral vasoconstriction associated with use of oxymetazoline nasal spray.
    Loewen AH; Hudon ME; Hill MD
    CMAJ; 2004 Sep; 171(6):593-4. PubMed ID: 15367461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis.
    Watanabe H; Foo TH; Djazaeri B; Duncombe P; Mackay IS; Durham SR
    Rhinology; 2003 Sep; 41(3):167-74. PubMed ID: 14579657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The curative effect of daphnlin spray on treating rhinitis].
    Yue J; Huang X; Tan H
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1999 Oct; 13(10):454-6. PubMed ID: 12541400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four-week use of oxymetazoline nasal spray (Nezeril) once daily at night induces rebound swelling and nasal hyperreactivity.
    Graf P; Hallén H; Juto JE
    Acta Otolaryngol; 1995 Jan; 115(1):71-5. PubMed ID: 7762389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis.
    Lieberman P; Kaliner MA; Wheeler WJ
    Curr Med Res Opin; 2005 Apr; 21(4):611-8. PubMed ID: 15899111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 2-week, crossover study to investigate the effect of fluticasone furoate nasal spray on short-term growth in children with allergic rhinitis.
    Gradman J; Caldwell MF; Wolthers OD
    Clin Ther; 2007 Aug; 29(8):1738-47. PubMed ID: 17919555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute coronary syndrome after nasal spray of oxymetazoline.
    Montastruc F; Montastruc G; Taudou MJ; Olivier-Abbal P; Montastruc JL; Bondon-Guitton E
    Chest; 2014 Dec; 146(6):e214-e215. PubMed ID: 25451367
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity.
    Graf P
    Rhinology; 1996 Mar; 34(1):9-13. PubMed ID: 8739860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline differences explain the apparent benefits of combining oxymetazoline with intranasal corticosteroids.
    Keiser PB; Nelson MR
    J Allergy Clin Immunol; 2011 Nov; 128(5):1132; author reply 132-3. PubMed ID: 21820715
    [No Abstract]   [Full Text] [Related]  

  • 12. Intranasal treatment of perennial allergic rhinitis. Comparison of azelastine nasal spray and budesonide nasal aerosol.
    Gastpar H; Aurich R; Petzold U; Dorow P; Enzmann H; Gering R; Köchy HP; Philippe A; Renz W; Wendenburg G
    Arzneimittelforschung; 1993 Apr; 43(4):475-9. PubMed ID: 8494580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal corticosteroid and oxymetazoline for chronic rhinitis: a systematic review.
    Neighbors CL; Salvador CF; Zhu B; Camacho M; Tsai P
    J Laryngol Otol; 2022 Jan; 136(1):8-16. PubMed ID: 34702392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of levocabastine in perennial rhinitis].
    Pacor ML; Biasi D; Maleknia T; Carletto A; Lunardi C
    Clin Ter; 1996 Jun; 147(6):295-8. PubMed ID: 8925638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of mometasone furoate aqueous nasal spray in the treatment of rhinitis medicamentosa: an experimental study.
    Tas A; Yagiz R; Yalcin O; Uzun C; Huseyinova G; Adali MK; Karasalihoglu AR
    Otolaryngol Head Neck Surg; 2005 Apr; 132(4):608-12. PubMed ID: 15806055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved strategies and new treatment options for allergic rhinitis.
    Willsie SK
    J Am Osteopath Assoc; 2002 Jun; 102(6 Suppl 2):S7-14. PubMed ID: 12090644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting adenosine receptors in the treatment of allergic rhinitis: a randomized, double-blind, placebo-controlled study.
    Rimmer J; Peake HL; Santos CM; Lean M; Bardin P; Robson R; Haumann B; Loehrer F; Handel ML
    Clin Exp Allergy; 2007 Jan; 37(1):8-14. PubMed ID: 17210036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azelastine nasal spray for allergic rhinitis.
    Med Lett Drugs Ther; 1997 May; 39(1000):45-7. PubMed ID: 9150688
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis.
    Rosenblut A; Bardin PG; Muller B; Faris MA; Wu WW; Caldwell MF; Fokkens WJ
    Allergy; 2007 Sep; 62(9):1071-7. PubMed ID: 17686110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of an intranasal house dust mite provocation model as a tool in clinical research.
    Oldenbeuving NB; KleinJan A; Mulder PG; Lumley P; de Groot EJ; van Drunen CM; Fokkens WJ
    Allergy; 2005 Jun; 60(6):751-9. PubMed ID: 15876304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.